5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one

C134H159F2N21O14 — CID 157181553

IUPAC5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
SMILESCC1(C)CCN(CC2CC2)C(=O)c2cc(COc3ccccc3)nn21.CC1(F)C[C@@H]1CN1CCn2nc(COc3cccc(F)c3)cc2C1=O.CC1CN(CC2CC2)C(=O)c2cc(COc3ccccc3)nn2C1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1[C@@H]1CC2CCC1C2
InChIInChI=1S/C20H23N3O2.2C20H25N3O2.2C19H23N3O2.C18H19F2N3O2.C18H21N3O2/c24-20-19-12-16(13-25-17-4-2-1-3-5-17)21-23(19)9-8-22(20)18-11-14-6-7-15(18)10-14;1-20(2)10-11-22(13-15-8-9-15)19(24)18-12-16(21-23(18)20)14-25-17-6-4-3-5-7-17;24-20-19-14-16(15-25-18-10-6-3-7-11-18)21-23(19)13-12-22(20)17-8-4-1-2-5-9-17;1-14-10-21(12-15-7-8-15)19(23)18-9-16(20-22(18)11-14)13-24-17-5-3-2-4-6-17;23-19-18-13-15(14-24-17-9-5-2-6-10-17)20-22(18)12-11-21(19)16-7-3-1-4-8-16;1-18(20)9-12(18)10-22-5-6-23-16(17(22)24)8-14(21-23)11-25-15-4-2-3-13(19)7-15;22-18-17-12-14(13-23-16-8-2-1-3-9-16)19-21(17)11-10-20(18)15-6-4-5-7-15/h1-5,12,14-15,18H,6-11,13H2;3-7,12,15H,8-11,13-14H2,1-2H3;3,6-7,10-11,14,17H,1-2,4-5,8-9,12-13,15H2;2-6,9,14-15H,7-8,10-13H2,1H3;2,5-6,9-10,13,16H,1,3-4,7-8,11-12,14H2;2-4,7-8,12H,5-6,9-11H2,1H3;1-3,8-9,12,15H,4-7,10-11,13H2/t14?,15?,18-;;;;;12-,18?;/m1....1./s1
InChIKeyAOPXCMUZIPCVDL-BEADNFJZSA-N
MW2325.87 g/mol
LogP22.08
Rot. Bonds31

About 5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one

5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one (PubChem CID 157181553) has the molecular formula C134H159F2N21O14 and a molecular weight of 2325.87 g/mol. Its IUPAC name is 5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one.

Molecular Properties

Compound Name5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
PubChem CID157181553
Molecular FormulaC134H159F2N21O14
Molecular Weight2325.87 g/mol
Exact Mass2324.23
IUPAC Name5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one
SMILESCC1(C)CCN(CC2CC2)C(=O)c2cc(COc3ccccc3)nn21.CC1(F)C[C@@H]1CN1CCn2nc(COc3cccc(F)c3)cc2C1=O.CC1CN(CC2CC2)C(=O)c2cc(COc3ccccc3)nn2C1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1[C@@H]1CC2CCC1C2
InChIInChI=1S/C20H23N3O2.2C20H25N3O2.2C19H23N3O2.C18H19F2N3O2.C18H21N3O2/c24-20-19-12-16(13-25-17-4-2-1-3-5-17)21-23(19)9-8-22(20)18-11-14-6-7-15(18)10-14;1-20(2)10-11-22(13-15-8-9-15)19(24)18-12-16(21-23(18)20)14-25-17-6-4-3-5-7-17;24-20-19-14-16(15-25-18-10-6-3-7-11-18)21-23(19)13-12-22(20)17-8-4-1-2-5-9-17;1-14-10-21(12-15-7-8-15)19(23)18-9-16(20-22(18)11-14)13-24-17-5-3-2-4-6-17;23-19-18-13-15(14-24-17-9-5-2-6-10-17)20-22(18)12-11-21(19)16-7-3-1-4-8-16;1-18(20)9-12(18)10-22-5-6-23-16(17(22)24)8-14(21-23)11-25-15-4-2-3-13(19)7-15;22-18-17-12-14(13-23-16-8-2-1-3-9-16)19-21(17)11-10-20(18)15-6-4-5-7-15/h1-5,12,14-15,18H,6-11,13H2;3-7,12,15H,8-11,13-14H2,1-2H3;3,6-7,10-11,14,17H,1-2,4-5,8-9,12-13,15H2;2-6,9,14-15H,7-8,10-13H2,1H3;2,5-6,9-10,13,16H,1,3-4,7-8,11-12,14H2;2-4,7-8,12H,5-6,9-11H2,1H3;1-3,8-9,12,15H,4-7,10-11,13H2/t14?,15?,18-;;;;;12-,18?;/m1....1./s1
InChIKeyAOPXCMUZIPCVDL-BEADNFJZSA-N
XLogP22.08
TPSA331.52 Ų
H-Bond Donors
H-Bond Acceptors28
Rotatable Bonds31
Heavy Atoms171
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002325.87
LogP ≤ 522.08
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1028

Analyze 5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one?
The IUPAC name of 5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one (CID 157181553) is 5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one.
What is the SMILES notation for 5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one?
The canonical SMILES for 5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one is CC1(C)CCN(CC2CC2)C(=O)c2cc(COc3ccccc3)nn21.CC1(F)C[C@@H]1CN1CCn2nc(COc3cccc(F)c3)cc2C1=O.CC1CN(CC2CC2)C(=O)c2cc(COc3ccccc3)nn2C1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1C1CCCCCC1.O=C1c2cc(COc3ccccc3)nn2CCN1[C@@H]1CC2CCC1C2.
What is the InChIKey of 5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one?
The InChIKey is AOPXCMUZIPCVDL-BEADNFJZSA-N. The full InChI is InChI=1S/C20H23N3O2.2C20H25N3O2.2C19H23N3O2.C18H19F2N3O2.C18H21N3O2/c24-20-19-12-16(13-25-17-4-2-1-3-5-17)21-23(19)9-8-22(20)18-11-14-6-7-15(18)10-14;1-20(2)10-11-22(13-15-8-9-15)19(24)18-12-16(21-23(18)20)14-25-17-6-4-3-5-7-17;24-20-19-14-16(15-25-18-10-6-3-7-11-18)21-23(19)13-12-22(20)17-8-4-1-2-5-9-17;1-14-10-21(12-15-7-8-15)19(23)18-9-16(20-22(18)11-14)13-24-17-5-3-2-4-6-17;23-19-18-13-15(14-24-17-9-5-2-6-10-17)20-22(18)12-11-21(19)16-7-3-1-4-8-16;1-18(20)9-12(18)10-22-5-6-23-16(17(22)24)8-14(21-23)11-25-15-4-2-3-13(19)7-15;22-18-17-12-14(13-23-16-8-2-1-3-9-16)19-21(17)11-10-20(18)15-6-4-5-7-15/h1-5,12,14-15,18H,6-11,13H2;3-7,12,15H,8-11,13-14H2,1-2H3;3,6-7,10-11,14,17H,1-2,4-5,8-9,12-13,15H2;2-6,9,14-15H,7-8,10-13H2,1H3;2,5-6,9-10,13,16H,1,3-4,7-8,11-12,14H2;2-4,7-8,12H,5-6,9-11H2,1H3;1-3,8-9,12,15H,4-7,10-11,13H2/t14?,15?,18-;;;;;12-,18?;/m1....1./s1.
What are the key properties of 5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one?
5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one has a molecular weight of 2325.87 g/mol, XLogP of 22.08, 31 rotatable bonds, 0 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[(2R)-2-bicyclo[2.2.1]heptanyl]-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cycloheptyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclohexyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-cyclopentyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one;5-(cyclopropylmethyl)-8,8-dimethyl-2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a][1,4]diazepin-4-one;5-(cyclopropylmethyl)-7-methyl-2-(phenoxymethyl)-7,8-dihydro-6H-pyrazolo[1,5-a][1,4]diazepin-4-one;5-[[(1R)-2-fluoro-2-methylcyclopropyl]methyl]-2-[(3-fluorophenoxy)methyl]-6,7-dihydropyrazolo[1,5-a]pyrazin-4-one is sourced from PubChem (CID 157181553), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).